Remed Co.,Ltd. (302550.KQ)
KOSDAQ · KRW · Healthcare · Medical Devices
₩2,320 (+2.43%) as of
Key statistics
- Market cap
- 69.03B
- Dividend yield
- 0.00%
- 52-week range
- 2,045.00 – 4,070.00
- Beta
- 0.72
- Revenue (TTM)
- 27.05B
- Profit margin
- 7.58%
- Volume
- 73.20k
About Remed Co.,Ltd.
Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In addition, the company provides extracorporeal shock wave therapy; and technology to activate the sensory function of prostate and strengthen the pelvic floor muscle by stimulating them with electromagnetic pulse. The company was formerly known as CR Technology Co., Ltd. and changed its name to Remed Co., Ltd. in 2013. Remed Co., Ltd. was founded in 2003 and is headquartered in Daejeon, South Korea.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Daejeon, South Korea
- Employees
- 88
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.